Gene · 6372
Papers3,275
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 3,275
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Recent advances on high-efficiency of microRNAs in different types of lung cancer: a comprehensive review. | Cancer Cell Int | 2023 | 37986065 | PubTator, text mining | PubMed |
| A novel neutrophil extracellular traps-related lncRNA signature predicts prognosis in patients with early-stage lung adenocarcinoma. | Ann Med | 2023 | 37980632 | PubTator, text mining | PubMed |
| Markers of inflammation predict survival in newly diagnosed cirrhosis: a prospective registry study. | Sci Rep | 2023 | 37973887 | PubTator, text mining | PubMed |
| Continuous detrimental activity of intra-articular fibrous scar tissue in correlation with posttraumatic ankle osteoarthritis. | Sci Rep | 2023 | 37973826 | PubTator, text mining | PubMed |
| Single-cell transcriptomics stratifies organoid models of metabolic dysfunction-associated steatotic liver disease. | EMBO J | 2023 | 37962490 | PubTator, text mining | PubMed |
A randomized, double-blind phase 1b study evaluating the safety, tolerability, pharmacokinetics and pharmacodynamics of the NLRP3 inhibitor selnoflast in patients with moderate to severe active ulcerative colitis. | Clin Transl Med | 2023 | 37962000 | PubTator, text mining | PubMed |
| A pan-cancer analysis of the MAPK family gene and their association with prognosis, tumor microenvironment, and therapeutic targets. | Medicine (Baltimore) | 2023 | 37960824 | PubTator, text mining | PubMed |
| Therapeutic Strategies for Pancreatic-Cancer-Related Type 2 Diabetes Centered around Natural Products. | Int J Mol Sci | 2023 | 37958889 | PubTator, text mining | PubMed |
| High USP32 expression contributes to cancer progression and is correlated with immune infiltrates in hepatocellular carcinoma. | BMC Cancer | 2023 | 37957631 | PubTator, text mining | PubMed |
| Chemokines, molecular drivers of thromboinflammation and immunothrombosis. | Front Immunol | 2023 | 37954596 | PubTator, text mining | PubMed |
| TWIST1 and TSG6 are coordinately regulated and function as potency biomarkers in human MSCs. | Sci Adv | 2023 | 37948519 | PubTator, text mining | PubMed |
| Pathogenicity and virulence of henipaviruses. | Virulence | 2023 | 37948320 | PubTator, text mining | PubMed |
| Ascorbate protects human kidney organoids from damage induced by cell-free hemoglobin. | Dis Model Mech | 2023 | 37942584 | PubTator, text mining | PubMed |
| CXCL17 binds efficaciously to glycosaminoglycans with the potential to modulate chemokine signaling. | Front Immunol | 2023 | 37942327 | PubTator, text mining | PubMed |
| Immuno-metabolic dendritic cell vaccine signatures associate with overall survival in vaccinated melanoma patients. | Nat Commun | 2023 | 37938561 | PubTator, text mining | PubMed |
| Bioinformatics analyses of potentially common pathogenic networks for primary Sjögren's syndrome complicated with acute myocardial infarction. | Sci Rep | 2023 | 37935719 | PubTator, text mining | PubMed |
| CALM3 affects the prognosis of leukemia and hemorrhoids. | Medicine (Baltimore) | 2023 | 37932969 | PubTator, text mining | PubMed |
| Atovaquone inhibits colorectal cancer metastasis by regulating PDGFRβ/NF-κB signaling pathway. | BMC Cancer | 2023 | 37932661 | PubTator, text mining | PubMed |
| Pathophysiological impact of CXC and CX3CL1 chemokines in preeclampsia and gestational diabetes mellitus. | Front Cell Dev Biol | 2023 | 37928902 | PubTator, text mining | PubMed |
| Structure-activity studies of Streptococcus pyogenes enzyme SpyCEP reveal high affinity for CXCL8 in the SpyCEP C-terminal. | Sci Rep | 2023 | 37923786 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6372/papers?page=15